© 1990 by Oxford University Press
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Judah Folkman
| You have reached the most complete version of this article accessible without further authentication.
More complete versions are available. Link to article |
Article topics:
- Oncology..Tumor Physiology
- Physiology..Mice
- Developmental Biology..Angiogenesis
- Physiology..Neovascularization
- Physiology..Nerves
- Oncology..Metastasis
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. H. Ozbudak, G. Ozbilim, I. Kucukosmanoglu, L. Dertsiz, and A. Demircan Vascular Endothelial Growth Factor Expression and Neovascularization in Non--Small Cell Lung Carcinoma International Journal of Surgical Pathology, October 1, 2009; 17(5): 390 - 395. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Jiang, M. K. Gnanasammandhan, and Y. Zhang Optical imaging-guided cancer therapy with fluorescent nanoparticles J R Soc Interface, September 16, 2009; (2009) rsif.2009.0243v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. G. SKOLDENBERG, A. LARSSON, A. JAKOBSON, F. HEDBORG, P. KOGNER, R. H. CHRISTOFFERSON, and F. AZARBAYJANI The Angiogenic Growth Factors HGF and VEGF in Serum and Plasma from Neuroblastoma Patients Anticancer Res, August 1, 2009; 29(8): 3311 - 3319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Schrader, C Kremling, M Klinger, H Laqua, and G Geerling Cultivation of lacrimal gland acinar cells in a microgravity environment Br J Ophthalmol, August 1, 2009; 93(8): 1121 - 1125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. O. Hanrahan, A. J. Ryan, H. Mann, S. J. Kennedy, P. Langmuir, R. B. Natale, R. S. Herbst, B. E. Johnson, and J. V. Heymach Baseline Vascular Endothelial Growth Factor Concentration as a Potential Predictive Marker of Benefit from Vandetanib in Non-Small Cell Lung Cancer Clin. Cancer Res., May 15, 2009; 15(10): 3600 - 3609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. Shah, B. S. Shin, J. Veith, K. Toth, R. J. Bernacki, and J. P. Balthasar Use of an Anti-Vascular Endothelial Growth Factor Antibody in a Pharmacokinetic Strategy to Increase the Efficacy of Intraperitoneal Chemotherapy J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 580 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Brantley-Sieders, G. Zhuang, D. Vaught, T. Freeman, Y. Hwang, D. Hicks, and J. Chen Host Deficiency in Vav2/3 Guanine Nucleotide Exchange Factors Impairs Tumor Growth, Survival, and Angiogenesis In vivo Mol. Cancer Res., May 1, 2009; 7(5): 615 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. H. Jung, S. H. Lee, E.-M. Ahn, and Y. M. Lee Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway Carcinogenesis, April 1, 2009; 30(4): 655 - 661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Saad, J. L. Lindner, Y. Liu, and J. F. Silverman Lymphangiogenesis in Esophageal Adenocarcinomas--Lymphatic Vessel Density as Prognostic Marker in Esophageal Adenocarcinoma Am J Clin Pathol, January 1, 2009; 131(1): 92 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Schmieder, S. D. Caruthers, H. Zhang, T. A. Williams, J. D. Robertson, S. A. Wickline, and G. M. Lanza Three-dimensional MR mapping of angiogenesis with {alpha}5{beta}1({alpha}{nu}{beta}3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model FASEB J, December 1, 2008; 22(12): 4179 - 4189. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tawada, T. Ishihara, A. Kobayashi, T. Yamaguchi, T. Tsuyuguchi, M. Matsuyama, and O. Yokosuka Quantitative Analysis of Vascular Endothelial Growth Factor in Liver Metastases from Pancreatic Carcinoma as a Predictor of Chemotherapeutic Effect and Prognosis Clin. Cancer Res., November 15, 2008; 14(22): 7438 - 7443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. O-charoenrat, I. Sarkaria, S. G. Talbot, P. Reddy, S. Dao, I. Ngai, A. Shaha, D. Kraus, J. Shah, V. Rusch, et al. SCCRO (DCUN1D1) Induces Extracellular Matrix Invasion by Activating Matrix Metalloproteinase 2 Clin. Cancer Res., November 1, 2008; 14(21): 6780 - 6789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Sun, W.-C. Chung, S.-H. Ryu, Z. Ju, H. T. Tran, E. Kim, J. M. Kurie, and J. S. Koo Cyclic AMP-Responsive Element Binding Protein- and Nuclear Factor-{kappa}B-Regulated CXC Chemokine Gene Expression in Lung Carcinogenesis Cancer Prevention Research, October 1, 2008; 1(5): 316 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takahashi, T. Kitahashi, R. Ishigamori, M. Mutoh, M. Komiya, H. Sato, Y. Kamanaka, M. Naka, T. Maruyama, T. Sugimura, et al. Increased expression of inducible nitric oxide synthase (iNOS) in N-nitrosobis(2-oxopropyl)amine-induced hamster pancreatic carcinogenesis and prevention of cancer development by ONO-1714, an iNOS inhibitor Carcinogenesis, August 1, 2008; 29(8): 1608 - 1613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z WIN, B ARIFF, C J HARVEY, P RANGI, R ECKERSLEY, K HAWTIN, and M J K BLOMLEY Comparative study of experienced vs non-experienced radiologists in assessing parametric CT images of the response of the prostate gland to radiotherapy Br. J. Radiol., July 1, 2008; 81(967): 572 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zou, M. Zhang, Q. Wang, D. Shang, L. Wang, and G. Yu Quantitative Investigation of Solitary Pulmonary Nodules: Dynamic Contrast-Enhanced MRI and Histopathologic Analysis Am. J. Roentgenol., July 1, 2008; 191(1): 252 - 259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Svatek, J. A. Karam, C. G. Roehrborn, P. I. Karakiewicz, K. M. Slawin, and S. F. Shariat Preoperative Plasma Endoglin Levels Predict Biochemical Progression After Radical Prostatectomy Clin. Cancer Res., June 1, 2008; 14(11): 3362 - 3366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C-Y Chai, W-T Chen, W-C Hung, W-Y Kang, Y-C Huang, Y-C Su, and C-H Yang Hypoxia-inducible factor-1{alpha} expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma J. Clin. Pathol., May 1, 2008; 61(5): 658 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Vaupel Hypoxia and Aggressive Tumor Phenotype: Implications for Therapy and Prognosis Oncologist, May 1, 2008; 13(suppl_3): 21 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Burstein, A. D. Elias, H. S. Rugo, M. A. Cobleigh, A. C. Wolff, P. D. Eisenberg, M. Lehman, B. J. Adams, C. L. Bello, S. E. DePrimo, et al. Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane J. Clin. Oncol., April 10, 2008; 26(11): 1810 - 1816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Y. Seiwert, D. J. Haraf, E. E.W. Cohen, K. Stenson, M. E. Witt, A. Dekker, M. Kocherginsky, R. R. Weichselbaum, H. X. Chen, and E. E. Vokes Phase I Study of Bevacizumab Added to Fluorouracil- and Hydroxyurea-Based Concomitant Chemoradiotherapy for Poor-Prognosis Head and Neck Cancer J. Clin. Oncol., April 1, 2008; 26(10): 1732 - 1741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. M. Merritt, Y. G. Lin, W. A. Spannuth, M. S. Fletcher, A. A. Kamat, L. Y. Han, C. N. Landen, N. Jennings, K. De Geest, R. R. Langley, et al. Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth J Natl Cancer Inst, March 5, 2008; 100(5): 359 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Karam, R. S. Svatek, P. I. Karakiewicz, A. Gallina, C. G. Roehrborn, K. M. Slawin, and S. F. Shariat Use of Preoperative Plasma Endoglin for Prediction of Lymph Node Metastasis in Patients with Clinically Localized Prostate Cancer Clin. Cancer Res., March 1, 2008; 14(5): 1418 - 1422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Kang, E. J. Kim, H. S. Kim, J. S. Sun, and Y. S. Jung Correlation of Whole-Breast Vascularity with Ipsilateral Breast Cancers Using Contrast-Enhanced MDCT Am. J. Roentgenol., February 1, 2008; 190(2): 496 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Choi and J.N. Myers Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy Journal of Dental Research, January 1, 2008; 87(1): 14 - 32. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Asayama, K. Yoshimitsu, Y. Nishihara, H. Irie, S. Aishima, A. Taketomi, and H. Honda Arterial Blood Supply of Hepatocellular Carcinoma and Histologic Grading: Radiologic-Pathologic Correlation Am. J. Roentgenol., January 1, 2008; 190(1): W28 - W34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Wasserman and A. R. Tan Evolving Strategies for the Treatment of "Triple-Negative" Breast Cancer ASCO Educational Book, January 1, 2008; 2008(1): 120 - 126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Miller, M. Wang, J. Gralow, M. Dickler, M. Cobleigh, E. A. Perez, T. Shenkier, D. Cella, and N. E. Davidson Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer N. Engl. J. Med., December 27, 2007; 357(26): 2666 - 2676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Kamat, W. M. Merritt, D. Coffey, Y. G. Lin, P. R. Patel, R. Broaddus, E. Nugent, L. Y. Han, C. N. Landen Jr., W. A. Spannuth, et al. Clinical and Biological Significance of Vascular Endothelial Growth Factor in Endometrial Cancer Clin. Cancer Res., December 15, 2007; 13(24): 7487 - 7495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. D. Culp, P. Tsagozis, M. Burgio, P. Russell, P. Pisa, and D. Garland Interference of Macrophage Migration Inhibitory Factor Expression in a Mouse Melanoma Inhibits Tumor Establishment by Up-Regulating Thrombospondin-1 Mol. Cancer Res., December 1, 2007; 5(12): 1225 - 1231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Lyshchik, A. C. Fleischer, J. Huamani, D. E. Hallahan, M. Brissova, and J. C. Gore Molecular Imaging of Vascular Endothelial Growth Factor Receptor 2 Expression Using Targeted Contrast-Enhanced High-Frequency Ultrasonography J. Ultrasound Med., November 1, 2007; 26(11): 1575 - 1586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. C. Rath, W. E. Huff, and G. R. Huff Thiram-Induced Changes in the Expression of Genes Relating to Vascularization and Tibial Dyschondroplasia Poult. Sci., November 1, 2007; 86(11): 2390 - 2395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P.B. O'Connor, G. C. Jayson, A. Jackson, D. Ghiorghiu, B. M. Carrington, C. J. Rose, S. J. Mills, R. Swindell, C. Roberts, C. L. Mitchell, et al. Enhancing Fraction Predicts Clinical Outcome following First-Line Chemotherapy in Patients with Epithelial Ovarian Carcinoma Clin. Cancer Res., October 15, 2007; 13(20): 6130 - 6135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Shi, Y. Huang, H. Zhou, X. Song, S. Yuan, Y. Fu, and Y. Luo Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin Blood, October 15, 2007; 110(8): 2899 - 2906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Wu, M. S. O'Reilly, R. R. Langley, R. Z. Tsan, C. H. Baker, N. Bekele, X. M. Tang, A. Onn, I. J. Fidler, and R. S. Herbst Expression of epidermal growth factor (EGF)/transforming growth factor-{alpha} by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice Mol. Cancer Ther., October 1, 2007; 6(10): 2652 - 2663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gridelli, P. Maione, A. Rossi, and F. De Marinis The Role of Bevacizumab in the Treatment of Non-Small Cell Lung Cancer: Current Indications and Future Developments Oncologist, October 1, 2007; 12(10): 1183 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Barb, C. J Williams, A. K Neuwirth, and C. S Mantzoros Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence Am. J. Clinical Nutrition, September 1, 2007; 86(3): 858S - 866S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. B. Nagengast, E. G. de Vries, G. A. Hospers, N. H. Mulder, J. R. de Jong, H. Hollema, A. H. Brouwers, G. A. van Dongen, L. R. Perk, and M. N. Lub-de Hooge In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft J. Nucl. Med., August 1, 2007; 48(8): 1313 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ayers, J. Fargnoli, A. Lewin, Q. Wu, and J. S. Platero Discovery and Validation of Biomarkers that Respond to Treatment with Brivanib Alaninate, a Small-Molecule VEGFR-2/FGFR-1 Antagonist Cancer Res., July 15, 2007; 67(14): 6899 - 6906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Peddinti, R. Zeine, D. Luca, R. Seshadri, A. Chlenski, K. Cole, B. Pawel, H. R. Salwen, J. M. Maris, and S. L. Cohn Prominent Microvascular Proliferation in Clinically Aggressive Neuroblastoma Clin. Cancer Res., June 15, 2007; 13(12): 3499 - 3506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Asosingh, S. Swaidani, M. Aronica, and S. C. Erzurum Th1- and Th2-Dependent Endothelial Progenitor Cell Recruitment and Angiogenic Switch in Asthma J. Immunol., May 15, 2007; 178(10): 6482 - 6494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Langley and I. J. Fidler Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis Endocr. Rev., May 1, 2007; 28(3): 297 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Murata and M. Moriyama Isoleucine, an Essential Amino Acid, Prevents Liver Metastases of Colon Cancer by Antiangiogenesis Cancer Res., April 1, 2007; 67(7): 3263 - 3268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, J. Chen, Y. Zhang, Z. Hu, D. Hu, Y. Pan, S. Ou, G. Liu, X. Yin, J. Zhao, et al. Panning and Identification of a Colon Tumor Binding Peptide from a Phage Display Peptide Library J Biomol Screen, April 1, 2007; 12(3): 429 - 435. [Abstract] [PDF]
|
|
|
|
|
|
H A Haroon, T F Patankar, X P Zhu, K L Li, N A Thacker, M J Scott, and A Jackson Comparison of cerebral blood volume maps generated from T2* and T1 weighted MRI data in intra-axial cerebral tumours Br. J. Radiol., March 1, 2007; 80(951): 161 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mujoomdar, J. H. M. Austin, R. Malhotra, C. A. Powell, G. D. N. Pearson, M. C. Shiau, and H. Raftopoulos Clinical Predictors of Metastatic Disease to the Brain from Non-Small Cell Lung Carcinoma: Primary Tumor Size, Cell Type, and Lymph Node Metastases Radiology, March 1, 2007; 242(3): 882 - 888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Lu, T. Bonome, Y. Li, A. A. Kamat, L. Y. Han, R. Schmandt, R. L. Coleman, D. M. Gershenson, R. B. Jaffe, M. J. Birrer, et al. Gene Alterations Identified by Expression Profiling in Tumor-Associated Endothelial Cells from Invasive Ovarian Carcinoma Cancer Res., February 15, 2007; 67(4): 1757 - 1768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Pezzolo, F. Parodi, M. V. Corrias, R. Cinti, C. Gambini, and V. Pistoia Tumor Origin of Endothelial Cells in Human Neuroblastoma J. Clin. Oncol., February 1, 2007; 25(4): 376 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gurlek, N. Karavitaki, O. Ansorge, and J. A H Wass What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and genetics Eur. J. Endocrinol., February 1, 2007; 156(2): 143 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. F. Redente, D. J. Orlicky, R. J. Bouchard, and A. M. Malkinson Tumor Signaling to the Bone Marrow Changes the Phenotype of Monocytes and Pulmonary Macrophages during Urethane-Induced Primary Lung Tumorigenesis in A/J Mice Am. J. Pathol., February 1, 2007; 170(2): 693 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yao, Y. Pan, J. Chen, X. Sun, Y. Qiu, and Y. Ding Endoglin (CD105) Expression in Angiogenesis of Primary Hepatocellular Carcinomas: Analysis using Tissue Microarrays and Comparisons with CD34 and VEGF Ann. Clin. Lab. Sci., January 1, 2007; 37(1): 39 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-M. Lee, E.-J. Lee, H.-Y. Hong, M.-K. Kwon, T.-H. Kwon, J.-Y. Choi, R.-W. Park, T.-G. Kwon, E.-S. Yoo, G.-S. Yoon, et al. Targeting Bladder Tumor Cells In vivo and in the Urine with a Peptide Identified by Phage Display Mol. Cancer Res., January 1, 2007; 5(1): 11 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sandler, R. Gray, M. C. Perry, J. Brahmer, J. H. Schiller, A. Dowlati, R. Lilenbaum, and D. H. Johnson Paclitaxel-Carboplatin Alone or with Bevacizumab for Non-Small-Cell Lung Cancer N. Engl. J. Med., December 14, 2006; 355(24): 2542 - 2550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W-Y. Hsieh, M-W. Chen, H-T. Ho, T-M. You, and Y-T. Lu Identification of differentially expressed proteins in human malignant pleural effusions Eur. Respir. J., December 1, 2006; 28(6): 1178 - 1185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F.J. Wippold II, M. Lammle, F. Anatelli, J. Lennerz, and A. Perry Neuropathology for the Neuroradiologist: Palisades and Pseudopalisades AJNR Am. J. Neuroradiol., November 1, 2006; 27(10): 2037 - 2041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Kim, J. A. Franklyn, K. Boelaert, M. C. Eggo, J. C. Watkinson, and C. J. McCabe Pituitary Tumor Transforming Gene (PTTG) Stimulates Thyroid Cell Proliferation via a Vascular Endothelial Growth Factor/Kinase Insert Domain Receptor/Inhibitor of DNA Binding-3 Autocrine Pathway J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4603 - 4611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Chen, M. E. Rose, H. Hwang, R. G. Nines, and G. D. Stoner Black raspberries inhibit N-nitrosomethylbenzylamine (NMBA)-induced angiogenesis in rat esophagus parallel to the suppression of COX-2 and iNOS Carcinogenesis, November 1, 2006; 27(11): 2301 - 2307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Heidemann, D G Binion, W Domschke, and T Kucharzik Antiangiogenic therapy in human gastrointestinal malignancies. Gut, October 1, 2006; 55(10): 1497 - 1511. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Schoffski, H. Dumez, P. Clement, A. Hoeben, H. Prenen, P. Wolter, S. Joniau, T. Roskams, and H. Van Poppel Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review Ann. Onc., August 1, 2006; 17(8): 1185 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yasui, H. Yamamoto, C. Y. Ngan, B. Damdinsuren, Y. Sugita, H. Fukunaga, J. Gu, M. Maeda, I. Takemasa, M. Ikeda, et al. Antisense to Cyclin D1 Inhibits Vascular Endothelial Growth Factor-Stimulated Growth of Vascular Endothelial Cells: Implication of Tumor Vascularization Clin. Cancer Res., August 1, 2006; 12(15): 4720 - 4729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Atri New Technologies and Directed Agents for Applications of Cancer Imaging J. Clin. Oncol., July 10, 2006; 24(20): 3299 - 3308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tokuhara, N. Hattori, H. Ishida, T. Hirai, M. Higashiyama, K. Kodama, and M. Miyake Clinical Significance of Aminopeptidase N in Non-Small Cell Lung Cancer. Clin. Cancer Res., July 1, 2006; 12(13): 3971 - 3978. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-i. Ueda, Y. Basaki, M. Yoshie, K. Ogawa, S. Sakisaka, M. Kuwano, and M. Ono PTEN/Akt Signaling through Epidermal Growth Factor Receptor Is Prerequisite for Angiogenesis by Hepatocellular Carcinoma Cells That Is Susceptible to Inhibition by Gefitinib. Cancer Res., May 15, 2006; 66(10): 5346 - 5353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Perrone, D Santini, A Verzi, B Vincenzi, D Borzomati, F Vecchio, R Coppola, A Antinori, P Magistrelli, G Tonini, et al. COX-2 expression in ampullary carcinoma: correlation with angiogenesis process and clinicopathological variables J. Clin. Pathol., May 1, 2006; 59(5): 492 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Mulkeen, T. Silva, P. S. Yoo, J. C. Schmitz, E. Uchio, E. Chu, and C. Cha Short Interfering RNA-Mediated Gene Silencing of Vascular Endothelial Growth Factor: Effects on Cellular Proliferation in Colon Cancer Cells Arch Surg, April 1, 2006; 141(4): 367 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Luo, Y.-J. Wen, Z.-Y. Ding, C.-H. Fu, Y. Wu, J.-Y. Liu, Q. Li, Q.-M. He, X. Zhao, Y. Jiang, et al. Immunotherapy of tumors with protein vaccine based on chicken homologous tie-2. Clin. Cancer Res., March 15, 2006; 12(6): 1813 - 1819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Kim, J. A. Franklyn, A. L. Stratford, K. Boelaert, J. C. Watkinson, M. C. Eggo, and C. J. McCabe Pituitary Tumor-Transforming Gene Regulates Multiple Downstream Angiogenic Genes in Thyroid Cancer J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1119 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. de Silva Rudland, L. Martin, C. Roshanlall, J. Winstanley, S. Leinster, A. Platt-Higgins, J. Carroll, C. West, R. Barraclough, and P. Rudland Association of S100A4 and Osteopontin with Specific Prognostic Factors and Survival of Patients with Minimally Invasive Breast Cancer Clin. Cancer Res., February 15, 2006; 12(4): 1192 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Tassi, R. T. Henke, E. T. Bowden, M. R. Swift, D. P. Kodack, A. H. Kuo, A. Maitra, and A. Wellstein Expression of a Fibroblast Growth Factor-Binding Protein during the Development of Adenocarcinoma of the Pancreas and Colon Cancer Res., January 15, 2006; 66(2): 1191 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Miller, M. Miller, S. Mehrotra, B. Agarwal, B. H. Mock, Q.-H. Zheng, S. Badve, G. D. Hutchins, and G. W. Sledge Jr. A Physiologic Imaging Pilot Study of Breast Cancer Treated with AZD2171 Clin. Cancer Res., January 1, 2006; 12(1): 281 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. H. Sun, Y. L. Sun, R. N. Fang, Y. Shao, H. C. Xu, Q. P. Xue, G. X. Ding, and Y. L. Cheng Expression of Cyclooxygenase-2 and Matrix Metalloproteinase-9 in Gastric Carcinoma and its Correlation with Angiogenesis Jpn. J. Clin. Oncol., December 1, 2005; 35(12): 707 - 713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Nilsson, R. R. Langley, and I. J. Fidler Interleukin-6, Secreted by Human Ovarian Carcinoma Cells, Is a Potent Proangiogenic Cytokine Cancer Res., December 1, 2005; 65(23): 10794 - 10800. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Demicheli, R. Miceli, A. Moliterni, M. Zambetti, W. J. M. Hrushesky, M. W. Retsky, P. Valagussa, and G. Bonadonna Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process Ann. Onc., September 1, 2005; 16(9): 1449 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Gong, Y. Jiang, L. Wang, D. Wei, J. Yao, S. Huang, S. Fang, and K. Xie Expression of Autocrine Motility Factor Correlates with the Angiogenic Phenotype of and Poor Prognosis for Human Gastric Cancer Clin. Cancer Res., August 15, 2005; 11(16): 5778 - 5783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-L. Pan, J.-H. Guh, C.-Y. Peng, S.-W. Wang, Y.-L. Chang, F.-C. Cheng, J.-H. Chang, S.-C. Kuo, F.-Y. Lee, and C.-M. Teng YC-1 [3-(5'-Hydroxymethyl-2'-furyl)-1-benzyl Indazole] Inhibits Endothelial Cell Functions Induced by Angiogenic Factors in Vitro and Angiogenesis in Vivo Models J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 35 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Marler, S. J. Fishman, S. M. Kilroy, J. Fang, J. Upton, J. B. Mulliken, P. E. Burrows, D. Zurakowski, J. Folkman, and M. A. Moses Increased Expression of Urinary Matrix Metalloproteinases Parallels the Extent and Activity of Vascular Anomalies Pediatrics, July 1, 2005; 116(1): 38 - 45. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. Thaker, S. Yazici, M. B. Nilsson, K. Yokoi, R. Z. Tsan, J. He, S.-J. Kim, I. J. Fidler, and A. K. Sood Antivascular Therapy for Orthotopic Human Ovarian Carcinoma through Blockade of the Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptors Clin. Cancer Res., July 1, 2005; 11(13): 4923 - 4933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Szoke, K. Kayser, J.-D. Baumhakel, I. Trojan, J. Furak, L. Tiszlavicz, J. Eller, and K. Boda Prognostic significance of microvascularization in cases of operated lung cancer Eur. J. Cardiothorac. Surg., June 1, 2005; 27(6): 1106 - 1111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Rosen VEGF-Targeted Therapy: Therapeutic Potential and Recent Advances Oncologist, June 1, 2005; 10(6): 382 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Herbst, A. Onn, and A. Sandler Angiogenesis and Lung Cancer: Prognostic and Therapeutic Implications J. Clin. Oncol., May 10, 2005; 23(14): 3243 - 3256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Miller, J. M. Trigo, C. Wheeler, A. Barge, J. Rowbottom, G. Sledge, and J. Baselga A Multicenter Phase II Trial of ZD6474, a Vascular Endothelial Growth Factor Receptor-2 and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients with Previously Treated Metastatic Breast Cancer Clin. Cancer Res., May 1, 2005; 11(9): 3369 - 3376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-F. Zhu, B.-F. Xie, J.-M. Zhou, G.-K. Feng, Z.-C. Liu, X.-Y. Wei, F.-X. Zhang, M.-F. Liu, and Y.-X. Zeng Blockade of Vascular Endothelial Growth Factor Receptor Signal Pathway and Antitumor Activity of ON-III (2',4'-Dihydroxy-6'-methoxy-3',5'-dimethylchalcone), a Component from Chinese Herbal Medicine Mol. Pharmacol., May 1, 2005; 67(5): 1444 - 1450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-T. Chen, C.-J. Huang, M.-T. Wu, S.-F. Yang, Y.-C. Su, and C.-Y. Chai Hypoxia-inducible Factor-1{alpha} is Associated with Risk of Aggressive Behavior and Tumor Angiogenesis in Gastrointestinal Stromal Tumor Jpn. J. Clin. Oncol., April 1, 2005; 35(4): 207 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Arora, J. Kaur, C. Sharma, M. Mathur, S. Bahadur, N. K. Shukla, S. V.S. Deo, and R. Ralhan Stromelysin 3, Ets-1, and Vascular Endothelial Growth Factor Expression in Oral Precancerous and Cancerous Lesions: Correlation with Microvessel Density, Progression, and Prognosis Clin. Cancer Res., March 15, 2005; 11(6): 2272 - 2284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dalal, A. M. Berry, C. J. Cullinane, D. C. Mangham, R. Grimer, I. J. Lewis, C. Johnston, V. Laurence, and S. A. Burchill Vascular Endothelial Growth Factor: A Therapeutic Target for Tumors of the Ewing's Sarcoma Family Clin. Cancer Res., March 15, 2005; 11(6): 2364 - 2378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Gong, L. Wang, J. C. Yao, J. A. Ajani, D. Wei, K. D. Aldape, K. Xie, R. Sawaya, and S. Huang Expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Expression of Vascular Endothelial Growth Factor in and Angiogenic Phenotype of Human Gastric Cancer Clin. Cancer Res., February 15, 2005; 11(4): 1386 - 1393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Hicklin and L. M. Ellis Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis J. Clin. Oncol., February 10, 2005; 23(5): 1011 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Miller, L. I. Chap, F. A. Holmes, M. A. Cobleigh, P. K. Marcom, L. Fehrenbacher, M. Dickler, B. A. Overmoyer, J. D. Reimann, A. P. Sing, et al. Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer J. Clin. Oncol., February 1, 2005; 23(4): 792 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S A Borg, K E Kerry, J A Royds, R D Battersby, and T H Jones Correlation of VEGF production with IL1{alpha} and IL6 secretion by human pituitary adenoma cells Eur. J. Endocrinol., February 1, 2005; 152(2): 293 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Popkov, N. Jendreyko, D. B. McGavern, C. Rader, and C. F. Barbas III Targeting Tumor Angiogenesis with Adenovirus-Delivered Anti-Tie-2 Intrabody Cancer Res., February 1, 2005; 65(3): 972 - 981. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fujita, I. Hayashi, S. Yamashina, A. Fukamizu, M. Itoman, and M. Majima Angiotensin type 1a receptor signaling-dependent induction of vascular endothelial growth factor in stroma is relevant to tumor-associated angiogenesis and tumor growth Carcinogenesis, February 1, 2005; 26(2): 271 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rehman and G. C. Jayson Molecular Imaging of Antiangiogenic Agents Oncologist, February 1, 2005; 10(2): 92 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Koster, J. H.J.M. van Krieken, M. A. MacKenzie, M. Schraders, G. F. Borm, J. A.W.M. van der Laak, W. Leenders, K. Hebeda, and J. M.M. Raemaekers Increased Vascularization Predicts Favorable Outcome in Follicular Lymphoma Clin. Cancer Res., January 1, 2005; 11(1): 154 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-H. Li, Z.-H. Miao, W.-F. Tan, J.-M. Yue, C. Zhang, L.-P. Lin, X.-W. Zhang, and J. Ding Pseudolaric Acid B Inhibits Angiogenesis and Reduces Hypoxia-Inducible Factor 1{alpha} by Promoting Proteasome-Mediated Degradation Clin. Cancer Res., December 15, 2004; 10(24): 8266 - 8274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Yanagawa, T Funasaka, S Tsutsumi, H Watanabe, and A Raz Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy Endocr. Relat. Cancer, December 1, 2004; 11(4): 749 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hoffmann, L. C. Hofbauer, V. Scharrenbach, A. Wunderlich, I. Hassan, S. Lingelbach, and A. Zielke Thyrotropin (TSH)-Induced Production of Vascular Endothelial Growth Factor in Thyroid Cancer Cells in Vitro: Evaluation of TSH Signal Transduction and of Angiogenesis-Stimulating Growth Factors J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6139 - 6145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Takemoto, H. Yano, S. Momosaki, S. Ogasawara, N. Nishida, S. Kojiro, T. Kamura, and M. Kojiro Antiproliferative Effects of Interferon-{alpha}Con1 on Ovarian Clear Cell Adenocarcinoma In vitro and In vivo Clin. Cancer Res., November 1, 2004; 10(21): 7418 - 7426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Vaupel The Role of Hypoxia-Induced Factors in Tumor Progression Oncologist, November 1, 2004; 9(suppl_5): 10 - 17. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||